Skip Navigation



NDT Advance Access published online on October 12, 2004

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh505
© 2004 by European Renal Association - European Dialysis and Transplant Association
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/12/3144    most recent
gfh505v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Butler, J. A.
Right arrow Articles by Mason, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, J. A.
Right arrow Articles by Mason, J. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received March 9, 2004
Accepted August 31, 2004


Original Articles

Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study

Janet A. Butler 1*, Robert C. Peveler 1, Paul Roderick 2, Peter W. F. Smith 3, Robert Horne 4, and Juan C. Mason 5

1 Mental Health Group, Community Clinical Sciences Research Division, University of Southampton, Royal South Hants Hospital, Southampton, UK
2 Health Care Research Unit, Community Clinical Sciences Research Division, University of Southampton, Southampton General Hospital, Southampton, UK
3 Southampton Statistical Sciences Research Institute, University of Southampton, Southampton, UK
4 Centre for Health Care Research, University of Brighton, Brighton, UK
5 Wessex Renal Unit, Queen Alexandra Hospital, Cosham, Portsmouth, UK

* To whom correspondence should be addressed. E-mail: jab7{at}soton.ac.uk.



  Abstract

Background. Non-adherence to immunosuppressants is a major cause of renal transplant failure.Interventions to improve adherence need to target modifiable risk factors.

Methods. Adherence was measured using the ‘gold standard’ measure of electronic monitoring in 58 adult renal transplant recipients from a UK transplant unit. Subjects were identified from a stratified random sample of 153 recipients recruited to a larger cross-sectional study comparing different measures of adherence. Inclusion criteria included age over 18 years and a functioning renal transplant, transplanted 6-63 months previously. Exclusion criteria included residence outside the region served by the unit and inability to give informed consent. Health beliefs, depression and functional status were measured using standardized questionnaires (Beliefs about Medicines Questionnaire, Illness Perception Questionnaire, Revised Clinical Interview Schedule and SF-36) and semi-structured interview. Transplant and demographic details were collected from the notes.

Results. Seven [12%, 95% confidence interval (CI) 4-20%] subjects missed at least 20% of days medication and 15 (26%, 15-37%) missed at least 10% of days. Lower belief in the need for medication and having a transplant from a live donor were the major factors associated with non-adherence. Depression was common, although not strongly associated with non-adherence.

Conclusions. Beliefs about medication are a promising target for interventions designed to improve adherence. The lower adherence in recipients of transplants from live donors needs confirming but may be clinically important in light of the drive to increase live donation.

Keywords: health beliefs; non-adherence; renal transplant.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
M. A. Chisholm-Burns, W. J. Kwong, L. L. Mulloy, and C. A. Spivey
Nonmodifiable characteristics associated with nonadherence to immunosuppressant therapy in renal transplant recipients
Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1242 - 1247.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. M. Buchanan, M. A. Schnitzler, D. C. Brennan, N. Dzebisashvili, L. M. Willoughby, D. Axelrod, P. R. Salvalaggio, K. C. Abbott, T. E. Burroughs, and K. L. Lentine
Novel Methods for Tracking Long-Term Maintenance Immunosuppression Regimens
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. M. Stirnemann, S. K. Takemoto, M. A. Schnitzler, D. C. Brennan, K. C. Abbott, P. Salvalaggio, T. E. Burroughs, J. A. Gavard, L. M. Willoughby, and K. L. Lentine
Agreement of Immunosuppression Regimens Described in Medicare Pharmacy Claims with the Organ Procurement and Transplantation Network Survey
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2299 - 2306.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.